Rong Stephanie Huang
Department of Medicine
The University of Chicago, USA
Dr. Huang is currently an Assistant Professor of Medicine; Director, the Pharmacogenomics of Anticancer Agents Research (PAAR) Cell Line Core; Member, Committee on Clinical Pharmacology and Pharmacogenomics, the University of Chicago Comprehensive Cancer Center, Center for Personalized Therapeutics, Committee on Cancer Biology at the University of Chicago. Dr. Huang is a member of American Association for Cancer Research (AACR), American Society of Human Genetics (ASHG) and American Society of Clinical Pharmacology and Therapeutics (ASCPT). She serves on the editorial board of Genomics, Proteinomics and Bioinformatics, and on Journal of Blood Disorders & Transfusion. She published more than 30 original research papers many of which are in high caliber journals, e.g., Nature Medicine, PNAS, Blood, Cancer Research and American Journal of Human Genetics.
My lab research focuses on translational pharmacogenomic research with particular interest in the pharmacogenomics of anticancer agents. By systematically evaluating the human genomes and their relationships to drug response and toxicity, our goal is to develop clinically useful models that predict risks for adverse drug reactions and non-response prior to administration of chemotherapy. We utilize cell lines (derived from healthy and disease individuals as well as commercially available cancer cell lines), and clinical samples to discover and functional characterize genetic variations, gene and microRNA (miRNA) expression for their role in chemotherapeutic sensitivity.